Bank of New York Mellon’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $713M | Sell |
|
|||||
|
2025
Q1 | $830M | Sell |
|
|||||
|
2024
Q4 | $708M | Sell |
|
|||||
|
2024
Q3 | $831M | Sell |
|
|||||
|
2024
Q2 | $861M | Sell |
|
|||||
|
2024
Q1 | $783M | Sell |
|
|||||
|
2023
Q4 | $804M | Sell |
|
|||||
|
2023
Q3 | $700M | Buy |
|
|||||
|
2023
Q2 | $703M | Sell |
|
|||||
|
2023
Q1 | $642M | Sell |
|
|||||
|
2022
Q4 | $601M | Buy |
|
|||||
|
2022
Q3 | $603M | Sell |
|
|||||
|
2022
Q2 | $591M | Buy |
|
|||||
|
2022
Q1 | $523M | Sell |
|
|||||
|
2021
Q4 | $453M | Sell |
|
|||||
|
2021
Q3 | $379M | Sell |
|
|||||
|
2021
Q2 | $426M | Sell |
|
|||||
|
2021
Q1 | $462M | Sell |
|
|||||
|
2020
Q4 | $539M | Sell |
|
|||||
|
2020
Q3 | $707M | Buy |
|
|||||
|
2020
Q2 | $729M | Buy |
|
|||||
|
2020
Q1 | $593M | Sell |
|
|||||
|
2019
Q4 | $549M | Sell |
|
|||||
|
2019
Q3 | $437M | Buy |
|
|||||
|
2019
Q2 | $473M | Buy |
|
|||||
|
2019
Q1 | $420M | Buy |
|
|||||
|
2018
Q4 | $365M | Sell |
|
|||||
|
2018
Q3 | $449M | Sell |
|
|||||
|
2018
Q2 | $396M | Sell |
|
|||||
|
2018
Q1 | $383M | Buy |
|
|||||
|
2017
Q4 | $303M | Buy |
|
|||||
|
2017
Q3 | $303M | Buy |
|
|||||
|
2017
Q2 | $255M | Sell |
|
|||||
|
2017
Q1 | $228M | Buy |
|
|||||
|
2016
Q4 | $153M | Sell |
|
|||||
|
2016
Q3 | $265M | Buy |
|
|||||
|
2016
Q2 | $260M | Sell |
|
|||||
|
2016
Q1 | $252M | Sell |
|
|||||
|
2015
Q4 | $453M | Sell |
|
|||||
|
2015
Q3 | $405M | Sell |
|
|||||
|
2015
Q2 | $536M | Sell |
|
|||||
|
2015
Q1 | $527M | Buy |
|
|||||
|
2014
Q4 | $465M | Buy |
|
|||||
|
2014
Q3 | $403M | Buy |
|
|||||
|
2014
Q2 | $315M | Buy |
|
|||||
|
2014
Q1 | $205M | Buy |
|
|||||
|
2013
Q4 | $208M | Sell |
|
|||||
|
2013
Q3 | $220M | Buy |
|
|||||
|
2013
Q2 | $214M | Buy |
|